Antioxidants may become an effective new therapy for Meniere's disease. - GreenMedInfo Summary

Abstract Title:

Radical scavengers for Ménière's disease after failure of conventional therapy: a pilot study.

Abstract Source:

Chem Biol Interact. 2010 Oct 6;188(1):144-50. PMID: 12953767

Abstract Author(s):

Masaya Takumida, Matti Anniko, Makiko Ohtani

Abstract:

OBJECTIVE: To perform a trial to assess the efficacy of radical scavengers, i.e. rebamipide, vitamin C and glutathione, for the treatment of Ménière's disease (MD). MATERIAL AND METHODS: Rebamipide (300 mg/day), vitamin C (600 mg/day) and/or glutathione (300 mg/day) were given orally for at least 8 weeks to 25 patients with poorly controlled MD. RESULTS: Of 22 patients, 21 showed marked improvement of vertigo; 12/27 ears showed improvement of hearing disorders; 17/27 ears showed improvement of tinnitus; and 18/25 patients showed improvement of disability. CONCLUSION: This study suggests that treatment using radical scavengers has the potential to become an effective new therapy for MD.

Article Published Date : Oct 06, 2010
Additional Links
Substances : Antioxidant formulas : CK(500) : AC(80)
Diseases : Meniere's Disease : CK(33) : AC(5)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Key Research Topics

Disease

Meniere's Disease

Substance

Antioxidant formulas

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2025 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.